# Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines

> **NCT01237977** · PHASE3 · COMPLETED · sponsor: **Medy-Tox** · enrollment: 314 (actual)

## Conditions studied

- Skin Aging

## Interventions

- **DRUG:** Botulinum Toxin Type A(Meditoxin®)
- **DRUG:** Botulinum Toxin Type A(Botox®)

## Key facts

- **NCT ID:** NCT01237977
- **Lead sponsor:** Medy-Tox
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11-23
- **Primary completion:** 2010-08-30
- **Final completion:** 2010-09-30
- **Target enrollment:** 314 (ACTUAL)
- **Last updated:** 2019-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01237977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01237977, "Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01237977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*